Adrian Franke to Prostatic Neoplasms
This is a "connection" page, showing publications Adrian Franke has written about Prostatic Neoplasms.
Connection Strength
0.269
-
Lee SA, Cai Q, Franke AA, Steinwandel M, Wu J, Wen W, Zheng W, Blot WJ, Shu XO. Associations of Subtype and Isomeric Plasma Carotenoids with Prostate Cancer Risk in Low-Income African and European Americans. Cancer Epidemiol Biomarkers Prev. 2021 10; 30(10):1846-1857.
Score: 0.103
-
Chai W, Cooney RV, Franke AA, Caberto CP, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN. Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2011 Apr; 20(4):708-10.
Score: 0.050
-
Gardner CD, Oelrich B, Liu JP, Feldman D, Franke AA, Brooks JD. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate. 2009 May 15; 69(7):719-26.
Score: 0.044
-
Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control. 2009 Sep; 20(7):1161-71.
Score: 0.044
-
Zhou JR, Yu L, Zhong Y, Nassr RL, Franke AA, Gaston SM, Blackburn GL. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate. 2002 Oct 01; 53(2):143-53.
Score: 0.028